Press Releases :: Enzo Biochem, Inc. (ENZ)

Skip to main content Skip to section navigation Skip to footer

Year

Release Type

Dec 30, 2015 9:00 am EST

Enzo Comments on Lone Star’s Decision to Withdraw Its Proxy Contest

Dec 28, 2015 2:15 pm EST

ISS Endorses Enzo’s Nominees for Company’s Board of Directors

Dec 23, 2015 11:11 am EST

Glass Lewis Supports Enzo Nominees for Company’s Board of Directors

Dec 22, 2015 12:26 pm EST

Enzo Biochem Issues Open Letter to Shareholders

Dec 7, 2015 4:15 pm EST

Enzo Biochem Reports Strong First Quarter

Dec 4, 2015 11:36 am EST

Enzo Biochem Schedules Teleconference to Discuss First Quarter 2016 Results Tuesday, December 8, 2015 at 8:30 AM E.T.

Nov 25, 2015 9:01 am EST

Enzo Biochem Releases New Investor Presentation on Corporate Strategy

Nov 17, 2015 8:30 am EST

Enzo Biochem Announces New York State Approval of Its First Assay Based on AmpiProbeTM Platform Aimed at Providing Affordable Molecular Diagnostics in Light of Reimbursement Pressure

Oct 29, 2015 12:19 pm EDT

Enzo Biochem Demonstrates Greater Sensitivity of Its AmpiProbe™ Platform for Molecular Diagnostics

Oct 13, 2015 8:00 am EDT

Enzo Biochem Reaches $10 Million Patent Infringement Settlement with Affymetrix, Inc.